Investment
Features
FeesSafety
Academy
More
Pluang+

Compare KraneShares CSI China Internet ETF (KWEB) vs GeneDx Holdings Corp (WGS) Price & Performance

KraneShares CSI China Internet ETFTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

KraneShares CSI China Internet ETF vs GeneDx Holdings Corp — how do they compare? KraneShares CSI China Internet ETF trades at $27.07, while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). Which is the better fit depends on your goals.

KWEBWGS
Sector
Sector/ThematicTechnology
52-Week High
$42.94$167.51
52-Week Low
$23.63$34.51
Market Cap
$1.80B
Enterprise Value
$1.80B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

KraneShares CSI China Internet ETF

KWEB is trading at $27.44, up 2.35% with bullish technical signals from moving averages. The ETF shows strong momentum with RSI indicators mixed but ADX suggesting trend strength. Recent news highlights China's focus on AI and technology sectors, with export controls and IPO activity creating both opportunities and regulatory uncertainties for Chinese internet companies.

The outlook remains cautiously optimistic given China's tech ambitions and attractive valuations, though geopolitical tensions and regulatory risks require careful monitoring. AI-driven growth potential is balanced by ongoing US-China trade tensions that could impact constituent companies.

GeneDx Holdings Corp

GeneDx Holdings (WGS) trades at $60.65, down 4.46% today, amid a bearish technical signal and multiple class-action lawsuits alleging securities fraud. The stock shows weak fundamentals with a negative net income margin of -17.58% and ROE of -30.42%, though it beat EPS estimates in two of the last three quarters. Revenue grew to $427.54M in 2025 but profitability remains a challenge, with a high EV/EBITDA of 161.17 indicating stretched valuation relative to earnings.

Despite a 90.9% analyst buy rating and a $75.40 consensus price target, significant risks from litigation and persistent losses cloud the outlook. The stock faces near-term pressure from legal overhangs, while operational cash flow turned negative in 2026. Investors should weigh high analyst optimism against substantial fundamental and legal headwinds before considering a position.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About KraneShares CSI China Internet ETF

KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.

Read more on KWEB

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS